A new study from scientists at The Scripps Research Institute (TSRI) shows that “holes” in HIV’s defensive sugar shield could be important in designing an HIV vaccine.
Source: HIV/AIDS news from Medical News Today
streeck
Kymouse, Kymab's human antibody discovery platform, successfully demonstrates steps to developing HIV vaccine
A new approach to developing a human vaccine against HIV has been developed by researchers at Kymab, a UK therapeutic antibody platform company, The Scripps Research Institute (TSRI) of San Diego…
Source: HIV/AIDS news from Medical News Today
Infant circumcision can be safely performed in rural Africa
A new study indicates that early infant circumcision, which helps to prevent HIV transmission later in life, can be safely performed in rural Uganda.
Source: HIV/AIDS news from Medical News Today
Gut bacteria metabolism impacts immune recovery in HIV-infected individuals, study finds
An international study coordinated by Spanish research institutes has found that gut bacteria also play their role in the immune recovery of HIV patients.
Source: HIV/AIDS news from Medical News Today
HIV-infected adults with depression have increased risk for heart attack
Among more than 26,000 human immunodeficiency virus (HIV)-infected adults, those with major depressive disorder (MDD) were more likely to experience a heart attack than those without MDD, according…
Source: HIV/AIDS news from Medical News Today
Study finds better definition of homelessness may help minimize HIV risk
Being homeless puts people at greater risk of HIV infection than those with stable housing, but targeting services to reduce risk behaviors is often complicated by fuzzy definitions of homelessness.
Source: HIV/AIDS news from Medical News Today
HIV: Newly discovered component could lead to more effective drugs
Scientists have uncovered a feature that HIV uses to infect cells while avoiding immune system detection. This finding could lead to improved treatments.
Source: HIV/AIDS news from Medical News Today
Patients with TB and HIV should receive prompt coordinated treatment for both conditions
Tuberculosis (TB) is a leading killer of people with HIV, and providing therapy for both illnesses simultaneously saves lives – according to new guidelines on the treatment of drug-susceptible TB…
Source: HIV/AIDS news from Medical News Today
HIV is not a super-spreader of drug-resistant tuberculosis
While the human immunodeficiency virus (HIV) pandemic fuels tuberculosis (TB) outbreaks, it does not drive the development and transmission of multidrug-resistance in TB patients as previously…
Source: HIV/AIDS news from Medical News Today
Early antiretroviral therapy dramatically reduces HIV DNA set point
A team of researchers, led by Drs. Merlin Robb and Jintanat Ananworanich of the U.S.
Source: HIV/AIDS news from Medical News Today